Liquidia, United Therapeutics Settle Patent Dispute, Keeping Yutrepia on Market
Liquidia announced a global settlement with United Therapeutics, ending years of litigation and securing continued sales of its Yutrepia inhalation powder for pulmonary arterial hypertension.